Summary
Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used throughout the world. This paper reviews the epidemiological data linking NSAID administration with gastrointestinal, hepatic, renal, haematological, and hypersensitivity reactions.
Meta-analysis has demonstrated that NSAIDs are associated with serious upper gastrointestinal disorders, with a relative risk of 2.7 in patients receiving NSAIDs compared with subjects not receiving NSAIDs. An increase in the dose and duration of NSAIDs and age >60 are associated with an increase in the risk of upper gastrointestinal toxicity. The current data strongly support a causal relationship between NSAIDs and gastrointestinal disorders.
Case-control studies have demonstrated an association between some NSAIDs and neutropenia, with a relative risk of between 3 and 9 in patients treated with NSAIDs compared with nonusers of these drugs.
NSAIDs have also been linked with hypersensitivity reactions, although the incidence of such reactions is very low. However, there are inconsistent data on the potential associations between NSAIDs and renal disease, and there are no epidemiological studies linking NSAIDs with acute liver disease.
Overall, the incidence of serious adverse reactions associated with NSAIDs is low, and this class of drugs can be regarded as being reasonably safe.
Similar content being viewed by others
References
Beard K, Lawson DH, Macfarlance GJ. Non-steroidal anti-inflammatory drugs and acute renal disease: a case control study. Pharmacoepidemiology and Drug Safety 1: 3–9, 1992
Bjarnson I. Non-steroidal antiinflammatory drug induced small intestinal inflammation in man. In Pounder R (Ed.) Recent advances in gastroenterology, Vol. 7, pp. 23–46, Churchill Livingstone, Edinburgh, 1988
Carson JL, Strom BL. Techniques of postmarketing surveillance: An overview. Medical Toxicology 1: 237–246, 1986
Carson JL, Strom BL, Duff A, Gupta A, Das K. Safety of NSAIDs with respect to acute liver disease. Archives of Internal Medicine, in press, 1993
Carson JL, Strom BL, Soper KA, West SL, Morse ML. The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Archives of Internal Medicine 147: 85–88, 1987
Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal antiinflammatory drugs. New England Journal of Medicine 310: 563–572, 1984
Fox DA, Jick H. Nonsteroidal anti-inflammatory drugs and renal disease. Journal of the American Medical Association 251: 1299–1300, 1984
Fries JF, Miller SR, Spitz PW, Williams CA, Hubert HB, et al. Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use. Gastroenterology 96: 646–655, 1989
Gabriel SE, Jaakkimainen L, Bombardier C. Risk of serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Annals of Internal Medicine 115: 787–796, 1991
Garcia Rodriguez LA, Gutthann SP, Walker AM, Lueck L. The role of non-steroidal anti-inflammatory drugs in acute liver injury. British Medical Journal 305: 865–868, 1992
Greenland S. Quantitative methods in the review of epidemio-logic literature. Epidemiologic Review 9: 1–30, 1987
Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray W. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Annals of Internal Medicine 114: 257–263, 1991
Gurwitz JH, Avorn J, Ross-Degan D, Lipsitz LA. Nonsteroidal anti-inflammatory drug-associated azotemia in the very old. Journal of the American Medical Association 264: 471–475, 1990
Helfgott SM, Sandberg-Cook J, Zakim D, Nestler J. Diclofenac-associated hepatotoxicity. Journal of the American Medical Association 264: 2660–2662, 1990
International Agranulocytosis and Aplastic Anemia Study Group. Risks of agranulocytosis and aplastic anemia: a first report of their relation to drug use with special reference to analgesics. Journal of the American Medical Association 256: 1749–1757, 1986
Jick H, Derby LE, Garcia Rodriguez LA, Jick SS, Dean AD. Liver disease associated with diclofenac, naproxen and piroxicam. Pharmacotherapy 12: 207–212, 1992
Johnson JH, Jick H, Hunter JR, Dickson JF. A follow-up study of ibuprofen users. Journal of Rheumatology 12: 549–552, 1985
Langman MJS. Epidemiologic evidence on the association between peptic ulceration and antiinflammatory drug use. Gastroenterology 96: 640–646, 1989
Murray MD, Brater CD, Tierney WM, Hui SL, McDonald CJ. Ibuprofen-associated renal impairment in a large general internal medicine practice. American Journal of Medical Science 299: 222–229, 1990
Roth SH. NSAID and gastropathy: a rheumatologist’s review. Journal of Rheumatology 15: 912–919, 1988
Sandier DP, Burr FR, Weinberg CR. Nonsteroidal anti-inflammatory drugs and the risk of chronic renal disease. Annals of Internal Medicine 115: 165–172, 1991
Soll AH, Weinstein WM, Kurata J, McCarthy D. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Annals of Internal Medicine 114: 307–319, 1991
Somerville K, Faulkner G, Langman M. Nonsteroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1: 462–464, 1986
Strom BL, Carson JL, Morse ML, West SL, Soper KA. The effect of indication on hypersensitivity reactions associated with zo-mepirac sodium and other nonsteroidal antiinflammatory drugs. Arthritis and Rheumatology 30: 1142–1148, 1987
Strom BL, Carson JL, Schinnar R, Sim E, Morse ML. The effect of indication on the risk of hypersensitivity reactions associated with tolmetin sodium vs. other nonsteroidal antiinflammatory drugs. Journal of Rheumatology 15: 695–699, 1988
Strom BL, Carson JL, Schinnar R, Snyder ES, Shaw M, et al. Nonsteroidal anti-inflammatory drugs and neutropenia. Archives of Internal Medicine, in press, 1993
Strom BL, West SL, Sim E, Carson JL. The epidemiology of the acute flank pain syndrome from suprofen. Clinical Pharmacology and Therapeutics 46: 693–699, 1989
Taggert HM, Alderice JM. Fatal cholestatic jaundice in elderly patients taking benoxaprofen. British Medical Journal 284: 1372, 1982
Zimmerman HJ. Update of hepatotoxicity due to classes of drugs in common clinical use: non-steroidal drugs, anti-inflammatory drugs, antibiotics, antihypertensives, and cardiac and psy-chotropic agents. Seminar on Liver Disease 10: 322–338, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carson, J.L., Rees Willett, L. Toxicity of Nonsteroidal Anti-Inflammatory Drugs. Drugs 46 (Suppl 1), 243–248 (1993). https://doi.org/10.2165/00003495-199300461-00063
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199300461-00063